Dupilumab improves pediatric type 2 asthma outcomes independent of patient baseline characteristics

Affiliations

• ¹ Fundación CIDEA, Buenos Aires, Argentina. Electronic address: [email protected].
• ² Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
• ³ Pediatric Pulmonology and Allergy Department, CHU Lille, Hôpital Jeanne de Flandre, Université de Lille, Lille, France.
• ⁴ Division of Allergy, Immunology and Pulmonary Medicine, Monroe Carell Jr. Children's Hospital at Vanderbilt University Medical Center, Nashville, Tenn.
• ⁵ Sanofi, Cambridge, Mass.
• ⁶ Sanofi, Bridgewater, NJ.
• ⁷ Regeneron Pharmaceuticals Inc., Tarrytown, New York, NY.